RxDoctor Payments Data

Gabriel Skiba, DO

Family Medicine · Camdenton, MONPI 1184286510

Payments from drug & device makers

$948in general payments, 2019–2025

Across 57 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$166
  • Novo Nordisk$122
  • Neurocrine Biosciences, Inc.$95
  • Teva Pharmaceuticals USA, Inc.$79
  • AstraZeneca$75
  • Otsuka America Pharmaceutical, Inc.$64
  • plus $348 from 16 others

What the payments were for

  • Food & beverage$948100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$948 in reported general payments places this provider in the 60th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$21,023
Medicare patients
225
Services billed
499

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide95$99,685
FarxigaDapagliflozin Propanediol105$78,591
XareltoRivaroxaban116$52,563
JanuviaSitagliptin Phosphate36$49,531
Invega SustennaPaliperidone Palmitate12$38,478
TrulicityDulaglutide24$37,964
EliquisApixaban124$33,610
JardianceEmpagliflozin134$26,828
Breztri AerosphereBudesonide/Glycopyr/Formoterol30$22,802
RybelsusSemaglutide13$14,807
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$12,758
XifaxanRifaximin14$10,920
Spiriva RespimatTiotropium Bromide14$8,709
DapagliflozinDapagliflozin Propanediol67$8,603
Tresiba Flextouch U-100Insulin Degludec11$8,279

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$122$114,491108 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$75$107,813156 claims
MerckJanuvia$14$49,53136 claims
Lilly USA, LLCTrulicity$30$37,96424 claims
Boehringer IngelheimJardiance, Spiriva Respimat$17$35,537148 claims
GSKTrelegy Ellipta$21$12,75819 claims
AbbVieFetzima$166$3,65929 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Camdenton

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →